Brief: Scilex Holding Company Amends Its License Agreement With Romeg Therapeutics, LLC, For The Worldwide Rights To Commercialize Gloperba
16/01/2025 20:40
Jan 16 (Reuters) - Scilex Holding Co SCLX.O :
* SCILEX HOLDING COMPANY AMENDS ITS LICENSE AGREEMENT WITH
ROMEG
THERAPEUTICS, LLC, FOR THE WORLDWIDE RIGHTS TO COMMERCIALIZE
GLOPERBA®, AN FDA-APPROVED PROPHYLACTIC TREATMENT FOR PAINFUL
GOUT FLARES IN ADULTS
Source text: ID:nGNX6DJvDk
Further company coverage: SCLX.O
(((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Scilex Holding
See all newsEnters Promissory Note With Vivasor For Revolving Credit Up To $20 Million, On Aug 8
Brief: Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens To List On Biconomy Exchange As Early As June 23, 2026
Brief: O+C Private Credit Wade Defendants Dispute Complaint And Statement By Scilex Holding Company
Company Enters Binding Term Sheet With Datavault Ai - SEC Filing
Company May Offer Up To $500 Million In Securities - SEC Filing